Bicycle Therapeutics (BCYC) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Bicycle Therapeutics (BCYC) over the last 8 years, with Q3 2025 value amounting to -$648.3 million.
- Bicycle Therapeutics' Enterprise Value rose 2722.5% to -$648.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$648.3 million, marking a year-over-year increase of 2722.5%. This contributed to the annual value of -$879.5 million for FY2024, which is 6707.48% down from last year.
- Per Bicycle Therapeutics' latest filing, its Enterprise Value stood at -$648.3 million for Q3 2025, which was up 2722.5% from -$721.5 million recorded in Q2 2025.
- In the past 5 years, Bicycle Therapeutics' Enterprise Value ranged from a high of -$195.9 million in Q1 2021 and a low of -$961.4 million during Q2 2024
- For the 5-year period, Bicycle Therapeutics' Enterprise Value averaged around -$508.3 million, with its median value being -$438.7 million (2021).
- Its Enterprise Value has fluctuated over the past 5 years, first tumbled by 22258.25% in 2021, then soared by 2788.05% in 2023.
- Quarter analysis of 5 years shows Bicycle Therapeutics' Enterprise Value stood at -$438.7 million in 2021, then grew by 22.69% to -$339.2 million in 2022, then tumbled by 55.22% to -$526.4 million in 2023, then tumbled by 67.07% to -$879.5 million in 2024, then rose by 26.29% to -$648.3 million in 2025.
- Its Enterprise Value was -$648.3 million in Q3 2025, compared to -$721.5 million in Q2 2025 and -$793.0 million in Q1 2025.